Metformin plus pentoxifylline versus prescriptive diet in non-alcoholic steatohepatitis (NASH): A randomized controlled pilot trial

Gastroenterologie Clinique et Biologique

Volumn 33, Issue 10-11, 2009, Pages 984-986

  Sturm, N ^a,b   Bronowicki, J P ^c   Maynard Muet, M ^d   Tran, A ^e   Heluwaert, F ^f   Plages, A ^a   Zarski, J P ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT ALBERT BONNIOT   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d HÔTEL DIEU   (France)

^e UNIVERSITY HOSPITAL OF NICE   (France)

^f Centre Hospitalier de la Region d'Annecy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; PENTOXIFYLLINE;

ARTHRALGIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET THERAPY; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG WITHDRAWAL; FATIGUE; HUMAN; INSOMNIA; LETTER; LIVER BIOPSY; LIVER HISTOLOGY; MULTICENTER STUDY; MYALGIA; NAUSEA; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PATIENT COUNSELING; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

BIOPSY; DIET; DRUG THERAPY, COMBINATION; FATTY LIVER; FREE RADICAL SCAVENGERS; HUMANS; HYPOGLYCEMIC AGENTS; LIVER; METFORMIN; PENTOXIFYLLINE; PILOT PROJECTS;

EID: 70350375687     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2009.05.010     Document Type: Letter

References (16)

1. Lemoine M. Stéatopathie métabolique : définition et histoire naturelle. Gastroenterol Clin Biol 33 (2009) 398-404
2. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Zoli M., and Melchionda N. Metformin in non-alcoholic steatohepatitis. Lancet 358 (2001) 893-894
3. Duman D.G., Ozdemir F., Birben E., Keskin O., Eksioglu-demiralp E., Celikel C., et al. Effects of pentoxifylline on TNF-alpha production by peripheral blood mononuclear cells in patients with non-alcoholic steatohepatitis. Dig Dis Sci 52 (2007) 2520-2524
4. Koppe S.W., Sahai A., Malladi P., Whitington P.F., and Green R.M. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. J Hepatol 41 (2004) 592-598
5. Yalniz M., Bahceioglu I.H., Kuzu N., Celebi S., Ataseven H., Ustündag B., et al. Amelioration of steatohepatitis with pentoxifylline in a novel non-alcoholic steatohepatitis model induced by high-fat diet. Dig Dis Sci 52 (2007) 2380-2386
6. Vial P., Riquelme A., Pizarro M., Solis N., Madariaga J.A., Aguayo G., et al. Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non-alcoholic steatohepatitis. Ann Hepatol 5 (2006) 25-29
7. Georgescu E.F., and Georgescu M. Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. J Gastrointestin Liver Dis 16 (2007) 39-46
8. Satapathy S.K., Sakhuja P., Malhotra V., Sharma B.C., and Sarin S.K. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol 22 (2007) 634-644
9. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
10. Bugianesi E., Gentilcore E., Manini R., Natale S., Vanni E., Villanova N., et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 100 (2005) 1082-1090
11. Duseja A., Das A., Dhiman R.K., Chawla Y.K., Thumburu K.T., Bhadada S., et al. Metformin is effective in achieving biochemical response in patients with non-alcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Ann Hepatol 6 (2007) 222-226
12. Loomba R., Lutchman G., Kleiner D.E., Ricks M., Feld J.J., Borg B.B., et al. Clinical trial: Pilot study of metformin for the treatment of nonalcoholic steatohepatitis. Aliment Pharmacol Ther 29 (2008) 172-182
13. Schwimmer J.B., Middleton M.S., Deutsch R., and Lavine J.E. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 21 (2005) 871-879
14. Uygun A., Kadayifci A., Isik A.T., Ozgurtas T., Deveci S., Tuzun A., et al. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 19 (2004) 537-544
15. Adams La, Zein Co, Angulo P., and Lindor K.D. A pilot trial of pentoxifylline in non-alcoholic steatohepatitis. Am J Gastroenterol 99 (2004) 2365-2368
16. Satapathy S.K., Garg S., Chauhan R., Sakhuja P., Malhotra V., Sharma B.C., et al. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with non-alcoholic steatohepatitis. Am J Gastroenterol 99 (2004) 1946-1952